Johnson Pharmacare Ratios

Johnson Pharmacare Ltd Ratios

The Johnson Pharmacare Ltd Ratios page provides a complete fundamental analysis of Johnson Pharmacare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Johnson Pharmacare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Johnson Pharmacare Ltd (NSE: , BSE: 532154) is currently trading at ₹0.57, with a market capitalization of ₹313.5M. As a major player in the Finance sector and Financial conglomerates industry, Johnson Pharmacare Ltd remains a key stock for fundamental analysis using Johnson Pharmacare Ltd Ratios.

Johnson Pharmacare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Johnson Pharmacare Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Johnson Pharmacare Ltd Ratios.

Historically, the Johnson Pharmacare Ltd P/E ratio has shown strong fluctuations:

The decline in Johnson Pharmacare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Johnson Pharmacare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Johnson Pharmacare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Johnson Pharmacare Ltd P/S ratio currently stands at 0, an important part of Johnson Pharmacare Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Johnson Pharmacare Ltd P/S ratio indicates cautious market sentiment.

Johnson Pharmacare Ltd Price to Cash Flow Ratio (P/CF)

The Johnson Pharmacare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Johnson Pharmacare Ltd Price to Cash Flow Ratio:

The declining Johnson Pharmacare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Johnson Pharmacare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Johnson Pharmacare Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Johnson Pharmacare Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Johnson Pharmacare Ltd EV/EBITDA ratio is currently 0, a key metric in Johnson Pharmacare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Johnson Pharmacare Ltd EV/EBITDA indicates balanced valuation.

Johnson Pharmacare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Johnson Pharmacare Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Johnson Pharmacare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Johnson Pharmacare Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Johnson Pharmacare Ltd Ratios Analysis Summary

The Johnson Pharmacare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Johnson Pharmacare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Johnson Pharmacare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.